The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 1,401–1,600 of 3,517
Metabotropic glutamate receptors – important modulators of nociception and pain behavior
Neugebauer, V. (2002) · Pain · doi:10.1016/s0304-3959(02)00140-9 · Cited by 164
On the role of general system theory for functional neuroimaging
Stephan, K. E. (2004) · Journal of Anatomy · doi:10.1111/j.0021-8782.2004.00359.x · Cited by 164
Norepinephine transporter inhibitors and their therapeutic potential
Zhou, J. (2004) · Drugs of the Future · doi:10.1358/dof.2004.029.12.855246 · Cited by 164
Origin of alternative splicing by tandem exon duplication
Kondrashov, F. A., & Koonin, E. V. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.23.2661 · Cited by 164
The Diagnosis, Symptomatology, and Epidemiology of Seasonal Affective Disorder
Magnusson, A., & Partonen, T. (2005) · CNS Spectrums · doi:10.1017/s1092852900019593 · Cited by 164
Westerink, B. H. C., Enrico, P., J, F., & Vries, J. B. D. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37396-3 · Cited by 164
Keck, M. E., Sillaber, I., Ebner, K., Welt, T., Toschi, N., Kaehler, S. T., Singewald, N., Philippu, A., Elbel, G. K., Wotjak, C. T., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00243.x · Cited by 164
Redrobe, J. P., Bourin, M., Colombel, M. C., & Baker, G. B. (1998) · Psychopharmacology · doi:10.1007/s002130050638 · Cited by 163
Proteomics in postgenomic neuroscience: the end of the beginning
Choudhary, J. S., & Grant, S. G. N. (2004) · Nature Neuroscience · doi:10.1038/nn1240 · Cited by 163
Perlman, W. R., Webster, M. J., Kleinman, J. E., & Weickert, C. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.006 · Cited by 163
Colwell, C. S., & Menaker, M. (1992) · Journal of Biological Rhythms · doi:10.1177/074873049200700204 · Cited by 163
Mørk, A., Kreilgaard, M., & Sánchez, C. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00138-2 · Cited by 163
Marion, S., Weiner, D. M., & Caron, M. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308742200 · Cited by 163
Tzavara, E. T., Bymaster, F. P., Felder, C. C., Wade, M., Gomeza, J., Wess, J., McKinzie, D. L., & Nomikos, G. G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001270 · Cited by 163
Trace amine receptors as targets for novel therapeutics: legend, myth and fact
BRANCHEK, T., & BLACKBURN, T. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00028-0 · Cited by 163
Li, B. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00070-6 · Cited by 162
Effects of Antipsychotic Drugs on Neurogenesis in the Forebrain of the Adult Rat
Wang, H.-D., Dunnavant, F. D., Jarman, T., & Deutch, A. Y. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300449 · Cited by 162
Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent
Higgins, G. A., Ballard, T. M., Kew, J. N. C., Richards, J. G., Kemp, J. A., Adam, G., Woltering, T. J., Nakanishi, S., & Mutel, V. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.018 · Cited by 162
The neuropsychopharmacological potential of neuroactive steroids
Rupprecht, R. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00060-x · Cited by 162
Massat, I., Souery, D., Del-Favero, J., Nothen, M., Blackwood, D., Muir, W., Kaneva, R., Serretti, A., Lorenzi, C., Rietschel, M., et al. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001615 · Cited by 162
Millan, M. J., Gobert, A., Lejeune, F., Newman‐Tancredi, A., Rivet, J., Auclair, A., & Péglion, J.-L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29415-5 · Cited by 162
Self-citationHas dopamine a physiological role in the control of sexual behavior?
Paredes, R. G., & Ågmo, A. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.001 · Cited by 161
Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease
Carney, R. M., Freedland, K. E., Veith, R. C., Cryer, P. E., Skala, J. A., Lynch, T., & Jaffe, A. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00049-3 · Cited by 161
AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors
van Kampen, M., Selbach, K., Schneider, R., Schiegel, E., Boess, F., & Schreiber, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1668-7 · Cited by 161
Simon, G. E., Von Korff, M., Rutter, C. M., & Peterson, D. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.395 · Cited by 161
Antidepressant-like properties of zinc in rodent forced swim test
Kroczka, B., Branski, P., Palucha, A., Pilc, A., & Nowak, G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00473-7 · Cited by 161
Diminished Anxiety- and Depression-Related Behaviors in Mice with Selective Deletion of theTac1Gene
Bilkei‐Gorzó, A., Rácz, I., Michel, K., & Zimmer, A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-10046.2002 · Cited by 161
Holsboer-Trachsler, E., Stohler, R., & Hatzinger, M. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90041-m · Cited by 160
Sanchez, C. J., Bailie, T. M., Wu, W.-R., Li, N., & Sorg, B. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00078-2 · Cited by 160
Ilouz, R., Kaidanovich, O., Gurwitz, D., & Eldar-Finkelman, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00636-8 · Cited by 160
Szegedi, A., Rujescu, D., Tadić, A., Müller, M., Kohnen, R., Stassen, H. H., & Dahmen, N. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500289 · Cited by 160
Genome evolution reveals biochemical networks and functional modules
von Mering, C., Zdobnov, E. M., Tsoka, S., Ciccarelli, F. D., Pereira‐Leal, J. B., Ouzounis, C., & Bork, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136809100 · Cited by 160
Harvey, B. H., Stein, D. J., Oosthuizen, F., Brand, L., & Wegener, G. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1836-4 · Cited by 160
Evidence for the Modulation of Sexual Behavior by α-Adrenoceptors in Male Rats
Clark, J. T., Smith, E. R., & Davidson, J. M. (2008) · Neuroendocrinology · doi:10.1159/000124151 · Cited by 160
Wegener, G., Volke, V., Harvey, B. H., & Rosenberg, R. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03738-1 · Cited by 160
Serotonin and drug reward: focus on 5-HT2C receptors
Higgins, G. A., & Fletcher, P. J. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.102 · Cited by 160
Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder
Liebowitz, M. R., Gelenberg, A. J., & Munjack, D. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.190 · Cited by 160
Schaffhauser, H., Rowe, B. A., Morales, S., Chavez-Noriega, L. E., Yin, R., Jachec, C., Rao, S. P., Bain, G., Pinkerton, A. B., Vernier, J.-M., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.798 · Cited by 160
Delayed pharmacological effects of antidepressants
Frazer, A., & Benmansour, S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001015 · Cited by 160
Yoshida, K., Takahashi, H., Higuchi, H., Kamata, M., Ito, K.-I., Sato, K., Naito, S., Shimizu, T., Itoh, K., Inoue, K., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1575 · Cited by 160
Bodkin, J. A., Lasser, R. A., Wines, J. D., Gardner, D. M., & Baldessarini, R. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0401 · Cited by 159
Modulation of Serotonin 2C Receptor Editing by Sustained Changes in Serotonergic Neurotransmission
Gurevich, I., Englander, M. T., Adlersberg, M., Siegal, N. B., & Schmauss, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10529.2002 · Cited by 159
Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine
Hebenstreit, G. F., Fellerer, K., Fichte, K., Fischer, G., Geyer, N., Meya, U., Sastre-y-Hernández, M., Schöny, W., Schratzer, M., Soukop, W., et al. (1989) · Pharmacopsychiatry · doi:10.1055/s-2007-1014599 · Cited by 159
Following the trace of elusive amines
Premont, R. T., Gainetdinov, R. R., & Caron, M. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181356198 · Cited by 159
Estrogens and non-reproductive behaviors related to activity and fear
Morgan, M., Schulkin, J. A., & Pfaff, D. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.017 · Cited by 159
Effects of antidepressants on cytokine production and actions
Castanon, N., Leonard, B. E., Neveu, P. J., & Yirmiya, R. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00008-9 · Cited by 159
Prevention of stress-induced morphological and cognitive consequences
McEwen, B. S., Conrad, C. D., Kuroda, Y., Frankfurt, M., Magariños, A. M., & McKittrick, C. R. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00064-3 · Cited by 159
Lipina, T., Labrie, V., Weiner, I., & Roder, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2210-x · Cited by 159
Busse, C. S., Brodkin, J., Tattersall, D., Anderson, J. J., Warren, N., Tehrani, L., Bristow, L. J., Varney, M. A., & Cosford, N. D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300540 · Cited by 159
van der Hart, M. G. C., Czéh, B., de Biurrun, G., Michaelis, T., Watanabe, T., Natt, O., Frahm, J., & Fuchs, E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001130 · Cited by 158
Neuropeptide Y is neuroproliferative for post‐natal hippocampal precursor cells
Howell, O. W., Scharfman, H. E., Herzog, H., Sundstrom, L. E., Beck‐Sickinger, A., & Gray, W. P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01895.x · Cited by 158
Khan, A., Khan, S. R., Walens, G., Kolts, R., & Giller, E. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300059 · Cited by 158
Costorage and coexistence of neuropeptides in the mammalian CNS
Merighi, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00031-4 · Cited by 158
Effects of Duloxetine on Painful Physical Symptoms Associated With Depression
Goldstein, D. J., Lu, Y., Detke, M. J., Hudson, J., Iyengar, S., & Demitrack, M. A. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.1.17 · Cited by 158
Transport of Monoamine Transmitters by the Organic Cation Transporter Type 2, OCT2
Gründemann, D., Koster, S. K., Kiefer, N., Breidert, T., Engelhardt, M., Spitzenberger, F., Obermüller, N., & Schömig, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30915 · Cited by 158
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
García‐Colunga, J., AWAD, J., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2041 · Cited by 158
Antidepressants: past, present and future
Vetulani, J., & Nalepa, I. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00565-3 · Cited by 158
Koch, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00377-9 · Cited by 158
Discrete synaptic states define a major mechanism of synapse plasticity
Montgomery, J. M., & Madison, D. V. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.10.006 · Cited by 158
Animal models of depression: are there any?
O'Neil, M. F., & Moore, N. A. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.496 · Cited by 157
Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability
Curzon, G., Gibson, E. L., & Oluyomi, A. O. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01003-6 · Cited by 157
Bech, P., Cialdella, P., Haugh, M., Birkett, M. A., Hours, A. T., Boissel, J., & Tollefson, G. D. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.176.5.421 · Cited by 157
A Meta-analytic Review of the Efficacy of Drug Treatment in Generalized Anxiety Disorder
Mitte, K., Noack, P., Steil, R., & Hautzinger, M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155821.74832.f9 · Cited by 157
Volke, V., Wegener, G., Bourin, M., & Vasar, E. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00312-1 · Cited by 157
Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour
Olivier, B., van Oorschot, R., & Waldinger, M. D. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199807006-00003 · Cited by 157
Stewart, C. A., & Reid, I. (2000) · Psychopharmacology · doi:10.1007/s002130050045 · Cited by 157
How Stress and Fluoxetine Modulate Serotonin 2C Receptor Pre-mRNA Editing
Englander, M. T., Dulawa, S. C., Bhansali, P., & Schmauss, C. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3895-04.2005 · Cited by 157
Jones, C. K., Peters, S. C., & Shannon, H. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075960 · Cited by 157
Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade
Cremers, T. I. F. H., Giorgetti, M., Bosker, F. J., Hogg, S., Arnt, J., Mørk, A., Honig, G., Bøgesø, K.-P., Westerink, B. H. C., den Boer, H., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300474 · Cited by 157
Jackson, H. C., Bearham, M. C., Hutchins, L. J., Mazurkiewicz, S. E., Needham, A. M., & Heal, D. J. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701311 · Cited by 157
Lammers, C.-H., Díaz, J., Jc, S., & Sokoloff, P. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000754 · Cited by 157
(1996) · PubMed · Cited by 156
de Saint-Hilaire, Z., Orosco, M., Rouch, C., Blanc, G., & Nicolaidis, S. (2001) · NeuroReport · doi:10.1097/00001756-200111160-00032 · Cited by 156
Kornhuber, J., & Quack, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11785-u · Cited by 156
Recent Advances in the Neurobiology of Schizophrenia
Miyamoto, S. (2003) · Molecular Interventions · doi:10.1124/mi.3.1.27 · Cited by 156
Search for a common mechanism of mood stabilizers
Harwood, A. J., & Agam, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00187-4 · Cited by 156
Molecular Evolution in Large Genetic Networks: Does Connectivity Equal Constraint?
Hahn, M. W., Conant, G. C., & Wagner, A. (2004) · Journal of Molecular Evolution · doi:10.1007/s00239-003-2544-0 · Cited by 156
Potential Antidepressive Properties of Amantadine, Memantine and Bifemelane
Moryl, E., Danysz, W., & Quack, G. (1993) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1993.tb01351.x · Cited by 156
Rational evolutionary design: The theory of in vitro protein evolution
Avoigt, C., Kauffman, S. A., & Wang, Z. (2001) · Advances in protein chemistry · doi:10.1016/s0065-3233(01)55003-2 · Cited by 155
Bupropion as an Antidote for Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Ashton, A. K., & Rosen, R. C. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0304 · Cited by 155
Appelberg, B., Syvälahti, E. K. G., Koskinen, T., Mehtonen, O. ‐., Muhonen, T. T., & Naukkarinen, H. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0608 · Cited by 155
α-Adrenoceptor modulation hypothesis of antipsychotic atypicality
Svensson, T. H. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.009 · Cited by 155
Dixon, J. F., & Hokin, L. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8363 · Cited by 155
Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans
Ellis, J. R., Ellis, K. A., Bartholomeusz, C. F., Harrison, B. J., Wesnes, K. A., Erskine, F. F., Vitetta, L., & Nathan, P. J. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005407 · Cited by 155
Treatment of Refractory Depression with High-Dose Thyroxine
Bauer, M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00181-4 · Cited by 155
Sibutramine: a review of the pharmacology of a novel anti-obesity agent.
Stock, M. (1997) · PubMed · Cited by 155
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months
Darreh‐Shori, T., Almkvist, O., Guan, Z. Z., Garlind, A., Strandberg, B., Svensson, A., Soreq, H., Hellström‐Lindahl, E., & Nordberg, A. K. (2002) · Neurology · doi:10.1212/wnl.59.4.563 · Cited by 154
Regulating the Conducting States of a Mammalian Serotonin Transporter
Quick, M. W. (2003) · Neuron · doi:10.1016/s0896-6273(03)00605-6 · Cited by 154
Female preproenkephalin-knockout mice display altered emotional responses
Ragnauth, A. K., Schuller, A. G., Morgan, M. A., Chan, J. S. W., Ogawa, S., Pintar, J. E., Bodnar, R. J., & Pfaff, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1958 · Cited by 154
Sleight, A. J., CAROLO, C., Petit, N., Zwingelstein, C., & Bourson, A. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08528-1 · Cited by 154
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment
Brunello, N., den Boer, J. A., Judd, L. L., Kasper, S., Kelsey, J. E., Lader, M., Lecrubier, Y., Lepine, J. P., Lydiard, R. B., Mendlewicz, J., et al. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00140-8 · Cited by 153
Delgado, P. L., Miller, H., Salomon, R. M., Licinio, J., Heninger, G. R., Gelenberg, A. J., & Charney, D. S. (1993) · PubMed · Cited by 153
Breit, A., Lagacé, M., & Bouvier, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313310200 · Cited by 153
Bartfai, T., Lü, X., Badie-Mahdavi, H., Barr, A. M., Mazarati, A. M., Hua, X., Yaksh, T. L., Haberhauer, G., Ceide, S. C., Trembleau, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403802101 · Cited by 153
Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model
Knapp, R. J., Goldenberg, R., Shuck, C., Cecil, A., Watkins, J. B., Miller, C., Crites, G. J., & Malatyńska, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01338-9 · Cited by 153
Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor
Fitzgerald, L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00004-4 · Cited by 153
Modulation of synaptic plasticity by stress and antidepressants
Popoli, M., Gennarelli, M., & Racagni, G. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01159.x · Cited by 153
Ferraro, L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00085-2 · Cited by 153
The Role of Sigma Receptors in Depression
Bermack, J. E., & Debonnel, G. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj04005x · Cited by 153
Sporn, J., Ghaemi, S. N., Sambur, M. R., Rankin, M. A., Recht, J., Sachs, G. S., Rosenbaum, J. F., & D, M. F. M. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009060800999 · Cited by 153
Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
Nickel, T., Sonntag, A., Schill, J., Zobel, A. W., Ackl, N., Brunnauer, A., Murck, H., Ising, M., Yassouridis, A., Steiger, A., et al. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00008 · Cited by 152
“Dopamine-Dependent” Side Effects of Selective Serotonin Reuptake Inhibitors
Damsa, C., Bumb, A., Bianchi-Demicheli, F., Vidailhet, P., Sterck, R., Andreoli, A., & Beyenburg, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0806 · Cited by 152
Rothschild, A. J., Williamson, D. J., Tohen, M. F., Schatzberg, A. F., Andersen, S. W., Campen, L. E. V., Sanger, T. M., & Tollefson, G. D. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130557.08996.7a · Cited by 152
Yorbık, Ö., Birmaher, B. B., Axelson, D., Williamson, D. E., & Ryan, N. D. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1210 · Cited by 152
Technological Advances in High-Throughput Screening
Liu, B., Li, S., & Hu, J. (2004) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200404040-00006 · Cited by 152
Neumeister, A., Turner, E. H., Matthews, J. R., Postolache, T. T., Barnett, R. L., Rauh, M., Vetticad, R. G., Kasper, S. F., & Rosenthal, N. E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.6.524 · Cited by 152
Meerlo, P., Overkamp, G. J. F., Benning, M. A., Koolhaas, J. M., & Van Den Hoofdakker, R. H. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02271-6 · Cited by 151
A Double Blind Comparison of Venlafaxine and Paroxetine in Obsessive-Compulsive Disorder
Denys, D., van der Wee, N., van Megen, H. J. G. M., & Westenberg, H. G. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095342.32154.54 · Cited by 151
Pharmacological Manipulations of the ??2-Noradrenergic System: Effects on Cognition
Coull, J. T. (1994) · Drugs & Aging · doi:10.2165/00002512-199405020-00005 · Cited by 151
Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats
Pilc, A., Kłodzińska, A., Brański, P., Nowak, G., Pałucha-Poniewiera, A., Szewczyk, B., Tatarczynska, E., Chojnacka-Wójcik, E., & Wierońska, J. M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00082-5 · Cited by 151
Rupniak, N. M. J., Carlson, E. J., Webb, J. K., Harrison, T., Porsolt, R. D., Roux, S., Felipe, C. D., Hunt, S. P., Oates, B. D., & Wheeldon, A. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00011 · Cited by 151
Current and Novel Approaches to the Drug Treatment of Schizophrenia
Rowley, M., Bristow, L. J., & Hutson, P. H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0002432 · Cited by 151
Chen, F., Larsen, M. B., Sánchez, C., & Wiborg, O. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.08.008 · Cited by 151
Azam, L., Winzer‐Serhan, U. H., & Leslie, F. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00220-3 · Cited by 151
Estrogen Replacement Therapy and Antidepressant Response to Sertraline in Older Depressed Women
Schneider, L. S. S., Small, G. W., & Clary, C. M. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00007 · Cited by 151
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression
Stahl, S. M., Entsuah, R., & Rudolph, R. L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01425-7 · Cited by 151
Role of serotonin2C receptors in the control of brain dopaminergic function
Matteo, V. D., Cacchio, M., Giulio, C. D., & Esposito, E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00705-5 · Cited by 151
Stein, M. B., & Heimberg, R. G. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00457-3 · Cited by 150
Evidence of an early information processing speed deficit in unipolar major depression
TSOURTOS, G., THOMPSON, J. C., & STOUGH, C. (2002) · Psychological Medicine · doi:10.1017/s0033291701005001 · Cited by 150
Towards a mechanism-based analysis of pharmacodynamic drug?drug interactions in vivo
Jonker, D. M., Visser, S. A. G., VANDERGRAAF, P., Voskuyl, R. A., & Danhof, M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.014 · Cited by 150
Devoto, P., Flore, G., Saba, P., Fà, M., & Gessa, G. L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02866.x · Cited by 150
Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors
Harkin, A., Connor, T., Walsh, M. P., John, N., & Kelly, J. P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00030-3 · Cited by 150
Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function
Fryer, J. D., & Lukas, R. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721117.x · Cited by 150
Stressor-induced anhedonia in the mesocorticolimbic system
Zacharko, R. M., & Anisman, H. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80032-6 · Cited by 150
Landén, M., Björling, G., Agren, H., & Fahlén, T. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1204 · Cited by 150
Diagnosis and Treatment of Depression in Alzheimer’s Disease
Lyketsos, C. G., & Lee, H. B. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074277 · Cited by 150
Buckett, W. R., Thomas, P. C., & Luscombe, G. P. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90003-6 · Cited by 150
Treatment of cocaine dependence and depression
Rounsaville, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.009 · Cited by 150
Lenox, R. H., & Wang, L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001306 · Cited by 150
The rationale for the use of dopamine agonists in Parkinson's disease
Jenner, P. G. (1995) · Neurology · doi:10.1212/wnl.45.3_suppl_3.s6 · Cited by 149
Involvement of 5-HT1C-receptors in drug-induced penile erections in rats
Berendsen, H. H. G., Jenck, F., & Broekkamp, C. L. E. (1990) · Psychopharmacology · doi:10.1007/bf02253718 · Cited by 149
BORDERLINE HYPOTHYROIDISM AND DEPRESSION
Haggerty, J. J., & Prange, A. J. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.37 · Cited by 149
SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats
Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P. D., Stevens, A. J., Deeks, N. J., Eddershaw, P. J., Fenwick, S. H., Riley, G. J., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705290 · Cited by 148
Quality of life and pain in Parkinson's disease: a controlled cross-sectional study
Quittenbaum, B. H., & Grahn, B. E. M. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.12.001 · Cited by 148
Genetics of personality: are we making progress?
Gestel, S. V., & Broeckhoven, C. V. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001367 · Cited by 148
Papakostas, G. I., Petersen, T., Nierenberg, A. A., Murakami, J. L., Alpert, J. E., Rosenbaum, J. F., & D, M. F. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0212 · Cited by 148
Benzodiazepine Use Among Depressed Patients Treated in Mental Health Settings
Valenstein, M. M., Taylor, K. K., Austin, K., Kales, H. C., McCarthy, J. F., & Blow, F. C. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.654 · Cited by 148
Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor
Skolnick, P., Popik, P., Janowsky, A. J., Beer, B., & LIPPA, A. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01310-4 · Cited by 148
Masaki, T., Yoshimatsu, H., Chiba, S., Watanabe, T., & Sakata, T. (2001) · Diabetes · doi:10.2337/diabetes.50.2.385 · Cited by 148
Memory retrieval enhancement by locus coeruleus stimulation: evidence for mediation by β-receptors
Devauges, V., & Sara, S. J. (1991) · Behavioural Brain Research · doi:10.1016/s0166-4328(05)80056-7 · Cited by 147
Antidepressant-like behavioral effects of serotonin receptor agonists
Lucki, I., Singh, A., & Kreiss, D. S. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90039-6 · Cited by 147
Grammatopoulos, D. K., Randeva, H. S., Levine, M. A., Kanellopoulou, K. A., & Hillhouse, E. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00067.x · Cited by 147
O’Brien, C. P., Charney, D. S., Lewis, L., Cornish, J., Post, R. M., WOODY, G. E., Zubieta, J., Anthony, J. C., BLAINE, J. D., Bowden, C. L., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.002 · Cited by 147
Möller, H., Volz, H., Reimann, I. W., & Stoll, K.-D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00011 · Cited by 147
Clifton, P. G., Lee, M. D., & Dourish, C. T. (2000) · Psychopharmacology · doi:10.1007/s002130000504 · Cited by 147
Schatzberg, A. F., Rush, A. J., Arnow, B. A., Banks, P. L. C., Blalock, J. A., Borian, F. E., Howland, R., Klein, D. N., Kocsis, J. H., Kornstein, S. G., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.5.513 · Cited by 147
Roles of Substance P and NK1 Receptor in the Brainstem in the Development of Emesis
Saito, R., Takano, Y., & Kamiya, H. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.91.87 · Cited by 146
Galvez, T., Prézeau, L., Milioti, G., Franěk, M., Joly, C., Froestl, W., Bettler, B., Bertrand, H., Blahoš, J., & Pin, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007848200 · Cited by 146
Tao, R., Ma, Z., & Auerbach, S. B. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16049.x · Cited by 146
The melanin-concentrating hormone: from the peptide to the gene.
Nahon, J. (1994) · PubMed · Cited by 146
Nicotinic–serotonergic interactions in brain and behaviour
Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00715-8 · Cited by 145
Zangen, A., & Hyodo, K. (2002) · NeuroReport · doi:10.1097/00001756-200212200-00005 · Cited by 145
5-HT1BReceptor–Mediated Presynaptic Inhibition of Retinal Input to the Suprachiasmatic Nucleus
Pickard, G. E., Smith, B. N., Belenky, M. A., Rea, M. A., Dudek, F. E., & Sollars, P. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04034.1999 · Cited by 145
Elevated agonist binding to α2-adrenoceptors in the locus coeruleus in major depression
Ordway, G. A., Schenck, J. E., Stockmeier, C. A., May, W., & Klimek, V. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01728-6 · Cited by 145
Gardner, C. J., Armour, D. R., Beattie, D. T., Gale, J. D., Hawcock, A. B., Kilpatrick, G. J., Twissell, D. J., & Ward, P. R. B. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(96)00071-7 · Cited by 145
Liégeois, J.-F., Ichikawa, J., & Meltzer, H. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02620-3 · Cited by 145
Neumaier, J., Root, D. C., & Hamblin, M. W. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00095-4 · Cited by 145
Anxiolytic-like activity of the mGluR5 antagonist MPEPA comparison with diazepam and buspirone
Brodkin, J. D., Busse, C. S., Rizzo, S. J. S., & Varney, M. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00828-6 · Cited by 145
Bonne, O. B., Grillon, C., Vythilingam, M., Neumeister, A., & Charney, D. S. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.12.001 · Cited by 145
Riad, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0950-04.2004 · Cited by 145
McEwen, B. S., & Olié, J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001648 · Cited by 145
Alternative splicing and evolution
Boué, S., Letunić, I., & Bork, P. (2003) · BioEssays · doi:10.1002/bies.10371 · Cited by 145
Ringdahl, E. N., Pereira, S. L., & Delzell, J. E. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.3.212 · Cited by 145
Generalized anxiety disorder: comorbidity, comparative biology and treatment
Nutt, D., Ballenger, J. C., Sheehan, D. V., & Wïttchen, H. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003048 · Cited by 145
Strategies for producing faster acting antidepressants
Adell, A., Castro, E., Celada, P., Bortolozzi, A., Pazos, Á., & Artigas, F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03398-2 · Cited by 145
Bai, F., Bergeron, M., & Nelson, D. L. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00104-7 · Cited by 144
A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104910.75206.b9 · Cited by 144
Glutamate co-transmission as an emerging concept in monoamine neuron function
Trudeau, L. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0431 · Cited by 144
Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation
Fone, K. C. F., Shalders, K., Fox, Z. D., Arthur, R., & Marsden, C. A. (1996) · Psychopharmacology · doi:10.1007/bf02246645 · Cited by 144
Redrobe, J. P., Dumont, Y., Herzog, H., & Quirion, R. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00374-1 · Cited by 144
Francis, P. T., Nordberg, A. K., & Arnold, S. E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.010 · Cited by 144
Vaidya, V. A., Terwilliger, R. Z., & Duman, R. S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00006-3 · Cited by 144
Which Factors Influence Psychiatrists’ Selection of Antidepressants?
Zimmerman, M. A., Posternak, M. A., Friedman, M. A., Attiullah, N., Baymiller, S., BOLAND, R. J., Berlowitz, S. L., Rahman, S., Uy, K. K., & Singer, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1285 · Cited by 144
Flanking gene and genetic background problems in genetically manipulated mice
Crusio, W. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.026 · Cited by 143
Peiffer, A. P., Veilleux, S., & Barden, N. (1991) · Psychoneuroendocrinology · doi:10.1016/0306-4530(91)90034-q · Cited by 143
Dopaminergic—adrenergic interactions in the wake promoting mechanism of modafinil
Wisor, J. P., & Eriksson, K. S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.003 · Cited by 143
Mendelson, W. (2004) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(03)00042-x · Cited by 142
Nefazodone: A Review of its Pharmacology and Clinical Efficacy in the Management of Major Depression
Davis, R., Whittington, R., & Bryson, H. M. (1997) · Drugs · doi:10.2165/00003495-199753040-00006 · Cited by 142
Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats
Stogner, K. A., & Holmes, P. V. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00800-6 · Cited by 142
Jay, T. M., Rocher, C., Hotte, M., Naudon, L., Gurden, H., & Spedding, M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033225 · Cited by 141
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder
Llorca, P., Spadone, C., Sol, O., Danniau, A., Bougerol, T., Corruble, E., Faruch, M., Macher, J.-P., Sermet, É., & Servant, D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1112 · Cited by 141
Thyroid Hormone, Neural Tissue and Mood Modulation
Bauer, M., & Whybrow, P. C. (2001) · The World Journal of Biological Psychiatry · doi:10.3109/15622970109027495 · Cited by 141
Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat
Dugovic, C., Wauquier, A., Leysen, J. E., Marrannes, R., & Janssen, P. A. J. (1989) · Psychopharmacology · doi:10.1007/bf00439544 · Cited by 141
Davis, R., & Wilde, M. I. (1996) · CNS Drugs · doi:10.2165/00023210-199605050-00007 · Cited by 141
Hodge, C. W., Raber, J., McMahon, T., Walter, M. H., Sánchez‐Pérez, A. M., Olive, M. F., Mehmert, K. K., Morrow, A. L., & Messing, R. O. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215903 · Cited by 141
Ranaldi, R., Pocock, D., Zereik, R., & Wise, R. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04102.1999 · Cited by 141
Zhang, H., Zhao, Y., Huang, Y., Dorairaj, N. R., Chandler, L. J., & O’Donnell, J. M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300440 · Cited by 141
Reddy, D. S., Kaur, G., & Kulkarni, S. K. (1998) · Neuroreport · doi:10.1097/00001756-199809140-00028 · Cited by 140
Ferraro, L., Antonelli, T., O'Connor, W. T., Tanganelli, S., Rambert, F. A., & Fuxé, K. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00353-3 · Cited by 140
Current perspectives on the development of non-biogenic amine-based antidepressants
Skolnick, P., Legutko, B., Li, X., & Bymaster, F. P. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0806 · Cited by 140
The evolution of comets in the Oort cloud and Kuiper belt
Stern, S. A. (2003) · Nature · doi:10.1038/nature01725 · Cited by 140
Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation
Sakata, T., Ookuma, K., Fukagawa, K., Fujimoto, K., Yoshimatsu, H., Shiraishi, T., & Wada, H. (1988) · Brain Research · doi:10.1016/0006-8993(88)91423-0 · Cited by 140
Youdim, M. B. H., WADIA, A., Tatton, W. G., & Weinstock, M. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03656.x · Cited by 140
Dawson, L. A., Nguyen, H. Q., & Li, P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703288 · Cited by 140
Lateral Hypothalamic Serotonin Inhibits Nucleus Accumbens Dopamine: Implications for Sexual Satiety
Lorrain, D. S., Riolo, J. V., Matuszewich, L., & Hull, E. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07648.1999 · Cited by 140
Froger, N., Gardier, A. M., Moratalla, R., Alberti, I., Léna, I., Boni, C., Felipe, C. D., Rupniak, N. M. J., Hunt, S. P., Jacquot, C., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08188.2001 · Cited by 140
Brotto, L. A., Barr, A. M., & Gorzalka, B. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00491-x · Cited by 139
Kanno, M., Matsumoto, M., Togashi, H., Yoshioka, M., & Mano, Y. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.08.013 · Cited by 139
Li, Q., Wichems, C. H., Ma, L., de Kar, L. D. V., García, F., & Murphy, D. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01607.x · Cited by 139
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Eisensamer, B., Rammes, G., Gimpl, G., Shapa, M., Ferrari, U., Hapfelmeier, G., Bondy, B., Parsons, C. G., Gilling, K. E., Zieglgänsberger, W., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001314 · Cited by 139
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.